9,025€
-1,63%
Echtzeit-Aktienkurs Aspen Pharmacare Holdings Ltd.
Bid:
Ask:
Echtzeit-Chart der Aspen Pharmacare Holdings Ltd. Aktie
Börsenkurse Aspen Pharmacare Holdings Ltd.
| Lang & Schwarz | - | - | - | - | 9,025€ | -1,63% |
| Tradegate | - | - | - | - | 8,975€ | 4,36% |
| Börse Stuttgart | - | - | - | - | 9,125€ | 0,83% |
| gettex | - | - | - | - | 9,150€ | -1,35% |
| Echtzeit Euro | - | - | - | - | 9,125€ | 6,10% |
| Börse Frankfurt | - | - | - | - | 9,350€ | 10,65% |
Fundamentaldaten der Aspen Pharmacare Holdings Ltd. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2024 [ZAR] | 44,71 Mrd. | 5,71 Mrd. | 4,40 Mrd. | 9,91 | 39,78% | 0,91 | 0,09 |
| 2023 [ZAR] | 40,71 Mrd. | 6,56 Mrd. | 5,23 Mrd. | 11,77 | 37,89% | 0,77 | 0,10 |
| 2022 [ZAR] | 38,61 Mrd. | 8,13 Mrd. | 6,49 Mrd. | 14,32 | 36,12% | 0,63 | 0,10 |
| 2021 [ZAR] | 37,77 Mrd. | 5,99 Mrd. | 4,41 Mrd. | 9,66 | 29,03% | 0,93 | 0,11 |
| 2020 [ZAR] | 38,65 Mrd. | 5,60 Mrd. | 4,86 Mrd. | 10,64 | - | 0,85 | 0,11 |
| 2019 [ZAR] | 38,87 Mrd. | 2,77 Mrd. | 2,12 Mrd. | 4,64 | - | 1,95 | 0,11 |
| 2018 [ZAR] | 42,60 Mrd. | 7,35 Mrd. | 6,01 Mrd. | 13,17 | 34,90% | 0,69 | 0,10 |
| 2017 [ZAR] | 41,20 Mrd. | 6,20 Mrd. | 5,10 Mrd. | 11,17 | 31,80% | 0,81 | 0,10 |
| 2016 [ZAR] | 35,60 Mrd. | 6,10 Mrd. | 4,30 Mrd. | 9,42 | 27,48% | 0,96 | 0,12 |
| 2015 [ZAR] | 36,13 Mrd. | 6,54 Mrd. | 5,20 Mrd. | 11,40 | 23,93% | 0,79 | 0,11 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Aspen Pharmacare Holdings Ltd. Aktie
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.